Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intravenous Zoledronic Acid on Bone Mineral Density in Osteoporosis Patients
KCT0003045Phase 4Recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in osteoporosis, sponsored by Daewoong Pharmaceutical. Started Apr 2018; status: recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on KCT0003045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003045.